Randomized, Open-label, Single-center, Four-way Crossover, Single Dose Study to Investigate the Pharmacokinetics of LAS41008 120 mg Gastro-resistant Tablet and Fumaderm® 120 mg Gastro-resistant Tablet Under Fasting and Fed Conditions in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 26 Dec 2016
At a glance
- Drugs Calcium monoethyl fumarate/dimethyl fumarate/magnesium monoethyl fumarate/zinc monoethyl fumarate (Primary) ; Dimethyl fumarate (Primary)
- Indications Plaque psoriasis
- Focus Pharmacokinetics
- Sponsors Almirall S.A.
- 21 Dec 2016 Status changed from active, no longer recruiting to completed.
- 09 Nov 2016 New trial record